Literature DB >> 32753483

Development of Noonan syndrome by deregulation of allosteric SOS autoactivation.

Hope Gloria Umutesi1, Hanh My Hoang1, Hope Elizabeth Johnson1, Kwangho Nam1, Jongyun Heo2.   

Abstract

Ras family proteins play an essential role in several cellular functions, including growth, differentiation, and survival. The mechanism of action of Ras mutants in Costello syndrome and cancers has been identified, but the contribution of Ras mutants to Noonan syndrome, a genetic disorder that prevents normal development in various parts of the body, is unknown. Son of Sevenless (SOS) is a Ras guanine nucleotide exchange factor. In response to Ras-activating cell signaling, SOS autoinhibition is released and is followed by accelerative allosteric feedback autoactivation. Here, using mutagenesis-based kinetic and pulldown analyses, we show that Noonan syndrome Ras mutants I24N, T50I, V152G, and D153V deregulate the autoactivation of SOS to populate their active form. This previously unknown process has been linked so far only to the development of Noonan syndrome. In contrast, other Noonan syndrome Ras mutants-V14I, T58I, and G60E-populate their active form by deregulation of the previously documented Ras GTPase activities. We propose a novel mechanism responsible for the deregulation of SOS autoactivation, where I24N, T50I, V152G, and D153V Ras mutants evade SOS autoinhibition. Consequently, they are capable of forming a complex with the SOS allosteric site, thus aberrantly promoting SOS autoactivation, resulting in the population of active Ras mutants in cells. The results of this study elucidate the molecular mechanism of the Ras mutant-mediated development of Noonan syndrome.
© 2020 Umutesi et al.

Entities:  

Keywords:  Noonan syndrome; Ras; Ras protein; SOS; Son of Sevenless; allosteric regulation; allostery; autoactivation; autoinhibition; catalysis; enzyme kinetics; guanine nucleotide exchange factor (GEF)

Mesh:

Substances:

Year:  2020        PMID: 32753483      PMCID: PMC7521655          DOI: 10.1074/jbc.RA120.013275

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Kinetic Mechanism of Formation of Hyperactive Embryonic Ras in Cells.

Authors:  Michael Wey; Jungwoon Lee; Hyo Sun Kim; Soon Seog Jeong; Jungho Kim; Jongyun Heo
Journal:  Biochemistry       Date:  2016-01-14       Impact factor: 3.162

Review 2.  Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.

Authors:  Angela Myers; Jonathan A Bernstein; Marie-Luise Brennan; Cynthia Curry; Edward D Esplin; Jamie Fisher; Margaret Homeyer; Melanie A Manning; Eric A Muller; Anna-Kaisa Niemi; Laurie H Seaver; Susan R Hintz; Louanne Hudgins
Journal:  Am J Med Genet A       Date:  2014-09-22       Impact factor: 2.802

3.  Differential Regulation of RasGAPs in Cancer.

Authors:  Thomas Grewal; Meryem Koese; Francesc Tebar; Carlos Enrich
Journal:  Genes Cancer       Date:  2011-03

4.  Allosteric gating of Son of sevenless activity by the histone domain.

Authors:  Kamlesh K Yadav; Dafna Bar-Sagi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-04       Impact factor: 11.205

5.  Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function.

Authors:  Jin-Young Shin; Michael Wey; Hope G Umutesi; Xiangle Sun; Jerry Simecka; Jongyun Heo
Journal:  J Biol Chem       Date:  2016-05-09       Impact factor: 5.157

Review 6.  Human RAS superfamily proteins and related GTPases.

Authors:  John Colicelli
Journal:  Sci STKE       Date:  2004-09-07

7.  Kinetic mechanisms of mutation-dependent Harvey Ras activation and their relevance for the development of Costello syndrome.

Authors:  Michael Wey; Jungwoon Lee; Soon Seog Jeong; Jungho Kim; Jongyun Heo
Journal:  Biochemistry       Date:  2013-11-13       Impact factor: 3.162

8.  Allosteric autoactivation of SOS and its kinetic mechanism.

Authors:  Hanh My Hoang; Hope Gloria Umutesi; Jongyun Heo
Journal:  Small GTPases       Date:  2019-04-13

9.  A restricted spectrum of NRAS mutations causes Noonan syndrome.

Authors:  Ion C Cirstea; Kerstin Kutsche; Radovan Dvorsky; Lothar Gremer; Claudio Carta; Denise Horn; Amy E Roberts; Francesca Lepri; Torsten Merbitz-Zahradnik; Rainer König; Christian P Kratz; Francesca Pantaleoni; Maria L Dentici; Victoria A Joshi; Raju S Kucherlapati; Laura Mazzanti; Stefan Mundlos; Michael A Patton; Margherita Cirillo Silengo; Cesare Rossi; Giuseppe Zampino; Cristina Digilio; Liborio Stuppia; Eva Seemanova; Len A Pennacchio; Bruce D Gelb; Bruno Dallapiccola; Alfred Wittinghofer; Mohammad R Ahmadian; Marco Tartaglia; Martin Zenker
Journal:  Nat Genet       Date:  2009-12-06       Impact factor: 38.330

10.  Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.

Authors:  Marco Tartaglia; Len A Pennacchio; Chen Zhao; Kamlesh K Yadav; Valentina Fodale; Anna Sarkozy; Bhaswati Pandit; Kimihiko Oishi; Simone Martinelli; Wendy Schackwitz; Anna Ustaszewska; Joel Martin; James Bristow; Claudio Carta; Francesca Lepri; Cinzia Neri; Isabella Vasta; Kate Gibson; Cynthia J Curry; Juan Pedro López Siguero; Maria Cristina Digilio; Giuseppe Zampino; Bruno Dallapiccola; Dafna Bar-Sagi; Bruce D Gelb
Journal:  Nat Genet       Date:  2006-12-13       Impact factor: 38.330

View more
  1 in total

Review 1.  The Role of Wild-Type RAS in Oncogenic RAS Transformation.

Authors:  Erin Sheffels; Robert L Kortum
Journal:  Genes (Basel)       Date:  2021-04-28       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.